Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer.
about
Cancer- and cancer treatment-associated cognitive change: an update on the state of the scienceMetformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in MiceWhat is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.Low-doses of cisplatin injure hippocampal synapses: a mechanism for 'chemo' brain?A prospective study of cognitive function in men with non-seminomatous germ cell tumors.Prevalence, mechanisms, and management of cancer-related cognitive impairment.Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy.Testicular cancer survivorship: research strategies and recommendations.Self-reported cognitive concerns and abilities: two sides of one coin?Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma.EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients.Impact of Bep or Carboplatin Chemotherapy on Testicular Function and Sperm Nucleus of Subjects with Testicular Germ Cell Tumor.Cognitive function in cancer survivors: analysis of the 1999-2002 National Health and Nutrition Examination SurveyFertility outcome of patients with testicular tumor: before and after treatment.Interventions for cognitive deficits in patients with a brain tumor: an update.Complications associated with chemotherapy in testicular cancer management.Minimizing toxicity in early-stage testicular cancer treatment.Review of recent studies on interventions for cognitive deficits in patients with cancer.Treatment-related problems experienced by cancer patients undergoing chemotherapy: a scoping review.The distress thermometer predicts subjective, but not objective, cognitive complaints six months after treatment initiation in cancer patients receiving a curative cancer treatment.Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting.Is psychological distress in men recently diagnosed with testicular cancer associated with their neuropsychological test performance?Patient's Cognitive Function and Attitudes Towards Family Involvement in Cancer Treatment Decision Making: A Patient-Family Caregiver Dyadic Analysis.Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy.Symptom burden in long-term germ cell tumor survivors.Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment.Long-term cognitive function following chemotherapy in patients with testicular cancer.Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors.A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors.Prevalence of cancer chemotherapy-related problems, their relation to health-related quality of life and associated supportive care: a cross-sectional survey.Cognitive impairment and potential biological and psychological correlates of neuropsychological performance in recently orchiectomized testicular cancer patients.Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors.Is chemotherapy associated with cognitive impairment?Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment.Cognitive impairment in men with testicular cancer prior to adjuvant therapy.A prospective study of neuropsychological functioning in testicular cancer patients.From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation.Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors.
P2860
Q26853289-3598E9C9-C8B6-4B43-B153-F163B601C1F1Q28551025-9924D300-A3C9-4293-8A13-1E4F516E98D9Q30249112-C1815322-5833-4229-8A3C-F757A525FCE5Q33763140-48BC5A3A-9E0B-4F5D-946C-A57460346A8AQ33790550-F33854E8-0828-4381-A68A-2B9E7575F283Q33854977-E0C2AB19-6185-45A8-9B8D-BBC63AC065D6Q33913619-86262E43-6E36-4171-BA2C-9E2EB00B9832Q34039684-7328CCBD-1BEF-411F-B2E5-73BC7DF698F8Q34288191-FE98C580-3432-4CF4-92BA-78E15B1C29DCQ34395112-AB2A1046-DA87-4929-A15F-A1D2985A5F77Q35206232-4654A03F-6AFE-465A-9EB7-E5E6192229D2Q35873287-50F70F2B-F5BC-4764-8567-063A9F11C415Q36896932-8644D777-C2F2-4940-9C4D-9963AE64D5EBQ37067793-F0ADE923-3274-4B76-944B-4B385A2AC4BDQ37514950-60608C0C-B009-47C0-9520-4D8D950F67FCQ37809863-72E98958-F7AC-4D24-88A7-1D5664680E43Q37853021-C946EF61-9BDD-46EB-AAB2-B8A37DBD49F4Q37982443-04DD92CD-51A1-406C-B807-D973017F0389Q37982452-4D28F7DB-375A-431E-898E-9E096421C520Q38258166-F0C0678D-C135-49C4-A2B0-11092E156700Q38620477-C524DA48-429F-4C09-A03D-31B4BE8B1E5AQ38820277-DD05D8FD-A93F-4F8A-999C-B5882E303C21Q39833079-2596E633-071B-4E57-8941-EC8F21B16DA9Q40125573-64B33EC4-745C-4529-A217-767205196A18Q40610815-42376D8B-441F-4658-AB69-9916DD8AF007Q41118556-63F7F93C-D8B3-4AA1-B5FC-90FEF4EC4807Q44305370-E7D46929-42A2-4A01-BC92-C91B35D0CCB1Q46128358-86DB4796-9D7B-454B-AA0B-12E612EE87DCQ46153881-0384A675-80BC-4EEE-BFEB-E231B9369D71Q47600423-B6E5E33D-A61E-4709-8D6A-1D691B714878Q47633407-9299F154-FE98-4303-A8A7-4FA08D5DE54EQ48086206-A1CA7546-D799-49CD-BCDC-632DB7AD29AEQ48204720-126F8CB8-13D5-42BD-B041-F1A82587295BQ48695193-5ACFDB28-7003-4123-A1B1-1E4AB9211581Q48706983-75FC3BAA-52B4-4124-96A8-6330DB2BD1C8Q49070604-4B280E40-A103-4035-B65A-8EE2F1C06050Q51830375-44BAE82E-DED8-410E-8112-4DDC9C3987CDQ55001002-CAA590D8-B757-413F-ACE5-2CA641A27CC0Q55162138-A4501601-649D-4D96-9419-1CD333AF1AE6
P2860
Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Cognitive complaints and cogni ...... tients with testicular cancer.
@en
Cognitive complaints and cogni ...... tients with testicular cancer.
@nl
type
label
Cognitive complaints and cogni ...... tients with testicular cancer.
@en
Cognitive complaints and cogni ...... tients with testicular cancer.
@nl
prefLabel
Cognitive complaints and cogni ...... tients with testicular cancer.
@en
Cognitive complaints and cogni ...... tients with testicular cancer.
@nl
P2093
P2860
P1433
P1476
Cognitive complaints and cogni ...... tients with testicular cancer.
@en
P2093
Frits S A M Van Dam
Luc Moonen
Martin J Muller
Sanne B Schagen
Willem Boogerd
Wim Meinhardt
Wim Ten Bokkel Huinink
P2860
P356
10.1080/02841860701518058
P577
2008-01-01T00:00:00Z